Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

Launched by HELWAN UNIVERSITY · Apr 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether an injection of calcium chloride can help reduce the occurrence of atrial fibrillation (a type of irregular heartbeat) in patients who are undergoing coronary artery bypass graft (CABG) surgery. Atrial fibrillation can happen after surgery and may lead to complications, so the researchers want to see if injecting calcium chloride into specific areas of the heart during the procedure can make a difference. Some patients will receive the calcium chloride injection, while others will receive a salt solution (sodium chloride) for comparison.

To be eligible for this trial, participants must be over 18 years old and scheduled for on-pump CABG surgery. However, those over 75 years old, with certain heart conditions, or serious liver or kidney issues, among other criteria, will not be included. If you participate, you can expect to receive either the calcium chloride or the salt solution during your surgery and be monitored for any changes in heart rhythm in the days following the procedure. This trial is currently recruiting participants of all genders and aims to better understand how calcium chloride might help improve heart health after surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) Patients more than 18 years old 2 ) patients undergoing On pump CABG
• Exclusion Criteria:
• • 1. patients \>75 years of age
• • 2. Patients with Pre operative Atrial fibrillation
• • 3. Patients with Significant valvular disease
• • 5. Ejection fraction \<30% 6. Combined surgery of any kind 7. Congenital heart disease 8. Abnormal severe liver or kidney dysfunction. 9. Patients undergoing Off-pump CABG 10. Poorly controlled hyperthyroidism 11. Refusal to enrollment.